Alterations of physostigmine-induced yawning by chronic lithium administration in rats

Pharmacology and Toxicology

Volumn 81, Issue 4, 1997, Pages 159-163

  Sharifzadeh, Mohammad ^a   Abdollahi, Mohammad ^a   Dehpour, Ahmad Reza ^b   Kebriaeezadeh, Abbas ^a   Samini, Mortaza ^b   Mohammad, Marjan ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; LITHIUM; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; PHYSOSTIGMINE; PIRENZEPINE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; YAWNING;

ANIMALIA; POROMITRA OSCITANS;

EID: 0030843045     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb02062.x     Document Type: Article

References (27)

1. Avissar, S., G. Schreiber, A. Danon & R. H. Belmaker: Lithium inhibits adrenergic and cholinergic increase in GTP binding in rat cortex. Nature 1988, 331, 440-442.
2. Barbizet, J.: Yawning. J. Neurol. Neurosurg. Psychiatry 1958, 21, 203-207.
3. Berridge, M. J. , C. P. Downes & M. R. Hanley: Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 1982, 206, 587-595.
4. Coffey, C. E., D. R. Ross, E. W. Massey & C. W. Olanow: Dyskinesia associated with lithium therapy in parkinsonism. Clin. Neuropharmacol. 1984, 7(3), 223-229.
5. Doods, H. N. , M. J. Mathy, D. Davidesko, K. J. Van Charldrop, A. de Longe & P.A. Van Zwieten: Selectivity of muscarinic antagonists in radioligand and in vivo experiments of the putative M1, M2 and M3 receptors. J. Pharmacol. Therap. 1987, 242, 257-262.
6. Dehpour, A. R. , M. Samini, M. Sharifzadeh & H. Hasan-Mazandarani: Effects of chronic lithium pretreatment on apomorphine-induced penile erection. Gen. Pharmacol. 1995, 26, 1015-1020.
7. Dehpour, A. R., T. Samadian & F. Roushanzamir: Interaction of aminoglycoside antibiotics and lithium at the neuromuscular junction. Drugs Explt. Clin. Res. 1992, 9, 383-387.
8. Ebstein, R. P., M. Hermoni & R. H. Belmaker : The Effect of lithium on noradrenaline induced cAMP accumulation in rat brain; inhibition after chronic treatment and absence of supersensitivity. J. Pharmacol. Exp. Therap. 1980, 213, 161-167.
9. Feuerstein, T. J., J. Lehmann, W. Savermann, V. Van Velthoren & JR. ackisch: The autoinhibitory feedback control of acetylcholine release in human neocortex tissue. Brain Res. 1992, 572(1-2), 64-71.
10. Gower, A. J.: Effects of acetylcholine agonists on yawning and analgesia in the rat. Eur. J. Pharmacol. 1987, 139, 79-89.
11. Hallcher, L. M. & W. R. Sherman: The effect of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 1980, 255, 10896-10901.
12. Hammer, R., C. P. Berrie, N. J. M. Birdsall, A. S. V. Burgen & E. C. Hulmet: Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 1980, 283, 90-92.
13. Hammer, R. & A. Giachetti: Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 1982, 31, 2991-2998.
14. Harden, T. K., T. Evans, J. R. Helper, A. R. Hughes, M. W. Martin, R. B. Meeker, M. M. Smith & L. I. Tanner: Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors. Adv. Cyclic Nucleotide Prot. Phosphorylat.Res. 1985, 19, 207-220.
15. Kendall, A. D. & S. R. Nahorski: acute and chronic lithium treatments influence agonist and depolarization-stimulated inositol phospholipid hydrolysis in rat cerebral cortex. J. Pharmacol. Exp. Therap. 1987, 241, 1023-1027.
16. Lefkwitz, R. J., B. B. Hoffman & P. Taylor: Neurohumoral transmission. In: Goodman and Gilmans: The pharmacological basis of therapeutics, 8th edi. Eds.: A. Goodman Gilman, L. S. Goodman, T. W. Rall, A. S. Nies & P. Taylor. Pergamon Press, New York, 1992, p. 100-101.
17. Massi, M., C. Polidori & C. Melchiorre: Methoctramine, a selective M2 alpnt agonist, doesnot inhibit carbacol-induced inking in the rat. Eur.J.Pharmacol. 1989, 163, 387-391.
18. Naharzki, S. R., C. I. Ragan & R. A. J. Challiss: Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequence. Trends Pharmacol. Sci. 1991, 12, 297-303.
19. Sharifzadeh, M. , A. R. Dehpour, M. Samini, H. Hasan-Mazandarani, T. Samadian & GH. Asghari: Alterations of bromocriptine-induced penile erection by chronic lithium in rats. J. Psychopharmacol. 1996, 10(2): 157-161.
20. Sharp, T., S. R. Bramwell, P. Lambert & D. G. Graham-Smith: Effects of short- and long- term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro. Neuropharmacology 1991, 30, 977-984.
21. Urba-Holmgren, R., R. M. Gonzalez & B. Holmgren: Is yawning a cholinergic response? Nature 1977, 267, 261-262.
22. Ushijima, I., K. Yamada, T. Inove, T. Tokunaga, T. Furukawa & Y. Noda: Muscarinic and nicotinic effects on yawning and tongue protruding in the rat. Pharmacol. Biochem. Behav. 1984, 21, 297-300.
23. Vizi, E. S., P. Illes, A. Ronai & J. Knoll: The effect of lithium on acetylcholine release and synthesis. Neuropharmacology 1972, 11, 521-530.
24. Wood, A. J. & G. M. Goodwin: A review of the biochemical and neuropharmacological actions of lithium. Psychol. Med. 1987, 17, 579-600.
25. Yamada, K. & T. Furukawa: Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psycopharmacology 1980, 67, 39-43.
26. Yamada, K. & T. Furukawa: The yawning elicited by melanocyte-stimulating hormone involves serotonergic dopaminergic cholinergic neuron link in rats. Naunyn Schmiedebergs Arch. Pharmacol. 1981, 316, 155-160.
27. Zarrindast, M. R., R. Adeli, S. Hosseini-Semnani & M. Sharifzadeh: Effects of adenosine receptor agonists and antagonists on physostigmine-induced yawning. Eur. J. Pharmacol. 1995, 267, 3-7.